Search Results - "LANG, Chim C"

Refine Results
  1. 1

    Anti-Inflammatory Effects of Metformin Irrespective of Diabetes Status by Cameron, Amy R, Morrison, Vicky L, Levin, Daniel, Mohan, Mohapradeep, Forteath, Calum, Beall, Craig, McNeilly, Alison D, Balfour, David J.K, Savinko, Terhi, Wong, Aaron K.F, Viollet, Benoit, Sakamoto, Kei, Fagerholm, Susanna C, Foretz, Marc, Lang, Chim C, Rena, Graham

    Published in Circulation research (19-08-2016)
    “…RATIONALE:The diabetes mellitus drug metformin is under investigation in cardiovascular disease, but the molecular mechanisms underlying possible benefits are…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Selenium and outcome in heart failure by Bomer, Nils, Grote Beverborg, Niels, Hoes, Martijn F., Streng, Koen W., Vermeer, Mathilde, Dokter, Martin M., IJmker, Jan, Anker, Stefan D., Cleland, John G.F., Hillege, Hans L., Lang, Chim C., Ng, Leong L., Samani, Nilesh J., Tromp, Jasper, Veldhuisen, Dirk J., Touw, Daan J., Voors, Adriaan A., Meer, Peter

    Published in European journal of heart failure (01-08-2020)
    “…Aims Severe deficiency of the essential trace element selenium can cause myocardial dysfunction although the mechanism at cellular level is uncertain. Whether,…”
    Get full text
    Journal Article
  4. 4

    Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial by Noman, Awsan, MB, Ang, Donald SC, MD, Ogston, Simon, PhD, Lang, Chim C, Prof, Struthers, Allan D, Prof

    Published in The Lancet (British edition) (19-06-2010)
    “…Summary Background Experimental evidence suggests that xanthine oxidase inhibitors can reduce myocardial oxygen consumption for a particular stroke volume. If…”
    Get full text
    Journal Article
  5. 5

    Targeting the renin–angiotensin–aldosterone system in heart failure by Lang, Chim C., Struthers, Allan D.

    Published in Nature reviews cardiology (01-03-2013)
    “…The renin–angiotensin–aldosterone system (RAAS) is well established as a therapeutic target in patients with heart failure. Professors Lang and Struthers…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Heart failure treatment up‐titration and outcome and age: an analysis of BIOSTAT‐CHF by Mordi, Ify R., Ouwerkerk, Wouter, Anker, Stefan D., Cleland, John G., Dickstein, Kenneth, Metra, Marco, Ng, Leong L., Samani, Nilesh J., Veldhuisen, Dirk J., Zannad, Faiez, Voors, Adriaan A., Lang, Chim C.

    Published in European journal of heart failure (01-03-2021)
    “…Aims Several studies have shown that older patients with heart failure with reduced ejection fraction (HFrEF) are undertreated. The aim of this study was to…”
    Get full text
    Journal Article
  13. 13

    Blood-based and Imaging Biomarkers of Atherosclerosis by Ali, Kashan, Lang, Chim C, Huang, Jeffrey T J, Choy, Anna-Maria

    Published in Cardiology in review (01-09-2023)
    “…Atherosclerosis is the main cause of arterial thrombosis, causing acute occlusive cardiovascular syndromes. Numerous risk prediction models have been…”
    Get full text
    Journal Article
  14. 14

    Left Ventricular Hypertrophy in Diabetic Cardiomyopathy: A Target for Intervention by Mohan, Mohapradeep, Dihoum, Adel, Mordi, Ify R, Choy, Anna-Maria, Rena, Graham, Lang, Chim C

    Published in Frontiers in cardiovascular medicine (29-09-2021)
    “…Heart failure is an important manifestation of diabetic heart disease. Before the development of symptomatic heart failure, as much as 50% of patients with…”
    Get full text
    Journal Article
  15. 15

    AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease by Wong, Aaron K F, Howie, Jacqueline, Petrie, John R, Lang, Chim C

    Published in Clinical science (1979) (01-04-2009)
    “…AMPK (AMP-activated protein kinase) is a heterotrimetric enzyme that is expressed in many tissues, including the heart and vasculature, and plays a central…”
    Get more information
    Journal Article
  16. 16

    Mechanistic Insights Into the Therapeutic Use of High-Dose Allopurinol in Angina Pectoris by Rajendra, Narasimharajapura S., MD, Ireland, Sheila, RGN, RM, George, Jacob, MD, Belch, Jill J.F., MD, Lang, Chim C., MD, Struthers, Allan D., MD

    “…Objectives The aim of this study was to evaluate the effect of high-dose allopurinol on vascular oxidative stress (OS) and endothelial function in subjects…”
    Get full text
    Journal Article
  17. 17

    COVID-19-Associated Cardiovascular Complications by Lee, Clement C. E., Ali, Kashan, Connell, David, Mordi, Ify R., George, Jacob, Lang, Elizabeth MSL, Lang, Chim C.

    Published in Diseases (29-06-2021)
    “…Coronavirus disease 2019 (COVID-19) has been reported to cause cardiovascular complications such as myocardial injury, thromboembolic events, arrhythmia, and…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Dapagliflozin, inflammation and left ventricular remodelling in patients with type 2 diabetes and left ventricular hypertrophy by Dihoum, Adel, Brown, Alexander Jm, McCrimmon, Rory J, Lang, Chim C, Mordi, Ify R

    Published in BMC cardiovascular disorders (12-07-2024)
    “…Sodium-glucose co-transporter 2 (SGLT2) inhibitors have beneficial effects in heart failure (HF), including reverse remodelling, but the mechanisms by which…”
    Get full text
    Journal Article
  20. 20

    Relationship between peripheral and coronary function using laser Doppler imaging and transthoracic echocardiography by Khan, Faisel, Patterson, Dean, Belch, Jill J F, Hirata, Kumiko, Lang, Chim C

    Published in Clinical science (1979) (01-11-2008)
    “…Vascular dysfunction in the coronary and peripheral circulations is an early prognostic marker of future cardiovascular events. Measurements of coronary and…”
    Get more information
    Journal Article